- Home
- GALT vs DTSQ Comparison
GALT vs DTSQ Comparison
Compare GALT & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- DTSQ
- Stock Information
- Founded
- GALT 2000
- DTSQ 2022
- Country
- GALT United States
- DTSQ United States
- Employees
- GALT N/A
- DTSQ N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- GALT Health Care
- DTSQ
- Exchange
- GALT Nasdaq
- DTSQ NYSE
- Market Cap
- GALT 83.5M
- DTSQ 91.7M
- IPO Year
- GALT N/A
- DTSQ 2024
- Fundamental
- Price
- GALT $1.31
- DTSQ $10.32
- Analyst Decision
- GALT Hold
- DTSQ
- Analyst Count
- GALT 1
- DTSQ 0
- Target Price
- GALT N/A
- DTSQ N/A
- AVG Volume (30 Days)
- GALT 176.3K
- DTSQ 3.3K
- Earning Date
- GALT 05-15-2025
- DTSQ 01-01-0001
- Dividend Yield
- GALT N/A
- DTSQ N/A
- EPS Growth
- GALT N/A
- DTSQ N/A
- EPS
- GALT N/A
- DTSQ 0.28
- Revenue
- GALT N/A
- DTSQ N/A
- Revenue This Year
- GALT N/A
- DTSQ N/A
- Revenue Next Year
- GALT N/A
- DTSQ N/A
- P/E Ratio
- GALT N/A
- DTSQ $36.82
- Revenue Growth
- GALT N/A
- DTSQ N/A
- 52 Week Low
- GALT $0.73
- DTSQ $9.96
- 52 Week High
- GALT $3.17
- DTSQ $10.37
- Technical
- Relative Strength Index (RSI)
- GALT 48.59
- DTSQ N/A
- Support Level
- GALT $1.22
- DTSQ N/A
- Resistance Level
- GALT $1.36
- DTSQ N/A
- Average True Range (ATR)
- GALT 0.10
- DTSQ 0.00
- MACD
- GALT -0.00
- DTSQ 0.00
- Stochastic Oscillator
- GALT 29.41
- DTSQ 0.00
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.